SUGT1P4-STRA6LP (Gene)

Description:SUGT1P4-STRA6LP readthrough

This locus is a fusion of a partial duplication of SUGT1 at the 5' end and the ortholog of mouse 1300002K09Rik (GeneID:74152) at the 3' end. A frameshift disrupts the potential open reading frame, so this locus is considered to be a transcribed pseudogene in humans. In addition, read-through transcripts extending into the downstream locus (GeneID:100499483) are observed. [provided by RefSeq, Aug 2010]

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View SUGT1P4-STRA6LP's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with SUGT1P4-STRA6LP.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using SUGT1P4-STRA6LP.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for SUGT1P4-STRA6LP.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with SUGT1P4-STRA6LP.

Results found

Linked to

	Label	Description
	GSE146982 metformin 4 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE197571 FOXM1 RNF112 overexpression MGC-803 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE146982 metformin 0 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE182710 Drp1 TFAM overexpression 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE228261 FDX1 overexpression WSU-DLCL2 Elesclomol 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE228261 elesclomol WSU-DLCL2 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE146982 metformin 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE196035 GSE196037 MEN1 inhibition 6 v 10 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE103567 EZH2 inhibition 5 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE186709 GSE186711 MLL inhibition 3 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS

GSE146982 metformin 4 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE197571 FOXM1 RNF112 overexpression MGC-803 2 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE146982 metformin 0 v 6 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE182710 Drp1 TFAM overexpression 1 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE228261 FDX1 overexpression WSU-DLCL2 Elesclomol 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE228261 elesclomol WSU-DLCL2 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE146982 metformin 0 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE196035 GSE196037 MEN1 inhibition 6 v 10 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE103567 EZH2 inhibition 5 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE186709 GSE186711 MLL inhibition 3 v 6 human dn

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.